SCHEMBL17279387

SCHEMBL17279387

COc1cccc(N2C(=O)c3ccc(C(=O)c4ccc5c(c4)C(=O)N(c4cccc(C=O)c4)C5=O)cc3C2=O)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.54
▸ ALDH1A1 P00352 6/20 0.49
▸ MEN1 O00255 5/20 0.49
▸ KMT2A Q03164 5/20 0.49
▸ HPGD P15428 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ CA1 P00915 2/20 0.48
▸ CA9 Q16790 2/20 0.48
▸ MAPT P10636 2/20 0.47
▸ RECQL P46063 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ LPAR1 Q92633 1/20 0.45
▸ LPAR5 Q9H1C0 1/20 0.45
▸ LPAR3 Q9UBY5 1/20 0.45
▸ CA12 O43570 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ ESR1 P03372 1/20 0.43
▸ S100B P04271 1/20 0.43
▸ NR1H3 Q13133 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17951023 0.91 HSD17B10 (0.63) HSD17B10ALDH1A1MEN1KMT2ACA1
SCHEMBL17278366 0.91 ALDH1A1 (0.55) HSD17B10ALDH1A1MEN1KMT2AMAPT
SCHEMBL17946143 0.82 HSD17B10 (0.54) HSD17B10ALDH1A1MEN1KMT2ACA1
SCHEMBL5010967 0.82 HSD17B10 (0.77) HSD17B10ALDH1A1MEN1KMT2ACA1
SCHEMBL17951022 0.78 ALDH1A1 (0.72) ALDH1A1MEN1KMT2ACA1CA9
SCHEMBL23285252 0.76 ALDH1A1 (0.41) HSD17B10ALDH1A1MEN1KMT2ACA1
SCHEMBL16917060 0.75 HSD17B10 (0.57) HSD17B10ALDH1A1MEN1KMT2AHPGD
SCHEMBL17946141 0.75 MAPK1 (0.64) HSD17B10ALDH1A1MEN1KMT2ACA1
SCHEMBL12639229 0.75 MGLL (0.57) HSD17B10ALDH1A1MEN1KMT2AHPGD
SCHEMBL14877713 0.74 HSD17B10 (0.76) HSD17B10ALDH1A1MEN1KMT2ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023540-B2 Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element TOKYO OHKA KOGYO CO., LTD. (JP) 2018-07-17 — — US disclosed
US-20180194930-A1 COMPOSITION CONTAINING MICROPARTICLES TOKYO OHKA KOGYO CO., LTD. (JP) 2018-07-12 — — US disclosed
US-9981914-B2 — — 2018-05-29 — — US disclosed
US-20180086717-A1 HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT TOKYO OHKA KOGYO CO., LTD. (JP) 2018-03-29 — — US disclosed
US-9890250-B2 Method for producing polybenzoxazole resin TOKYO OHKA KOGYO CO., LTD. (JP) 2018-02-13 — — US disclosed
US-20170115563-A1 ENERGY-SENSITIVE RESIN COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2017-04-27 — — US disclosed
US-20150337084-A1 METHOD FOR PRODUCING POLYBENZOXAZOLE RESIN TOKYO OHKA KOGYO CO., LTD. (JP) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194930-A1 COMPOSITION CONTAINING MICROPARTICLES CHMP4B, EXOSC10, EXOSC9 HSD17B10 4476/4885ALDH1A1 1737/4885MEN1 200/4885
US-20180086717-A1 HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT SLC9A2, SLC9A1, NHERF1 HSD17B10 794/4885ALDH1A1 3686/4885MEN1 626/4885
US-10023540-B2 Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element SLC9A2, SLC9A1, NHERF1 HSD17B10 794/4885ALDH1A1 3686/4885MEN1 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback